XML 64 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue - Disaggregation of Net Sales by Segment and Division (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Oct. 30, 2020
Oct. 25, 2019
Oct. 30, 2020
Oct. 25, 2019
Disaggregation of Revenue [Line Items]        
Net sales $ 7,647 $ 7,706 $ 14,154 $ 15,199
Cardiac & Vascular Group        
Disaggregation of Revenue [Line Items]        
Net sales 2,725 2,855 5,158 5,645
Cardiac & Vascular Group | Cardiac Rhythm & Heart Failure        
Disaggregation of Revenue [Line Items]        
Net sales 1,426 1,426 2,673 2,807
Cardiac & Vascular Group | Coronary & Structural Heart        
Disaggregation of Revenue [Line Items]        
Net sales 831 955 1,611 1,896
Cardiac & Vascular Group | Aortic, Peripheral, & Venous        
Disaggregation of Revenue [Line Items]        
Net sales 468 474 873 942
Minimally Invasive Therapies Group        
Disaggregation of Revenue [Line Items]        
Net sales 2,285 2,142 4,086 4,242
Minimally Invasive Therapies Group | Surgical Innovations        
Disaggregation of Revenue [Line Items]        
Net sales 1,393 1,454 2,473 2,871
Minimally Invasive Therapies Group | Respiratory, Gastrointestinal, & Renal        
Disaggregation of Revenue [Line Items]        
Net sales 893 688 1,613 1,371
Restorative Therapies Group        
Disaggregation of Revenue [Line Items]        
Net sales 2,063 2,112 3,774 4,124
Restorative Therapies Group | Cranial & Spinal Technologies        
Disaggregation of Revenue [Line Items]        
Net sales 1,071 1,117 2,015 2,167
Restorative Therapies Group | Specialty Therapies        
Disaggregation of Revenue [Line Items]        
Net sales 581 575 1,035 1,138
Restorative Therapies Group | Neuromodulation        
Disaggregation of Revenue [Line Items]        
Net sales 411 420 725 818
Diabetes Group        
Disaggregation of Revenue [Line Items]        
Net sales $ 574 $ 596 $ 1,136 $ 1,188